These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8226840)

  • 1. The carboxyl terminus of nerve growth factor is required for biological activity.
    Drinkwater CC; Barker PA; Suter U; Shooter EM
    J Biol Chem; 1993 Nov; 268(31):23202-7. PubMed ID: 8226840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of NH2-terminal residues of nerve growth factor affects activity and Trk binding without affecting stability or conformation.
    Woo SB; Timm DE; Neet KE
    J Biol Chem; 1995 Mar; 270(11):6278-85. PubMed ID: 7890765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activity.
    Shih A; Laramee GR; Schmelzer CH; Burton LE; Winslow JW
    J Biol Chem; 1994 Nov; 269(44):27679-86. PubMed ID: 7961687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
    Kullander K; Ebendal T
    J Neurosci Res; 1994 Oct; 39(2):195-210. PubMed ID: 7837289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational studies of conserved residues in the dimer interface of nerve growth factor.
    Guo M; Meyer SL; Kaur H; Gao JJ; Neet KE
    Protein Sci; 1996 Mar; 5(3):447-55. PubMed ID: 8868481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two restricted sites on the surface of the nerve growth factor molecule independently determine specific TrkA receptor binding and activation.
    Kullander K; Kaplan D; Ebendal T
    J Biol Chem; 1997 Apr; 272(14):9300-7. PubMed ID: 9083066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells.
    Barker PA; Shooter EM
    Neuron; 1994 Jul; 13(1):203-15. PubMed ID: 7519025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkA cross-linking mimics neuronal responses to nerve growth factor.
    Clary DO; Weskamp G; Austin LR; Reichardt LF
    Mol Biol Cell; 1994 May; 5(5):549-63. PubMed ID: 7919537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses.
    LeSauteur L; Wei L; Gibbs BF; Saragovi HU
    J Biol Chem; 1995 Mar; 270(12):6564-9. PubMed ID: 7896793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the nerve growth factor carboxyl terminus in receptor binding and conformational stability.
    Krüttgen A; Heymach JV; Kahle PJ; Shooter EM
    J Biol Chem; 1997 Nov; 272(46):29222-8. PubMed ID: 9361001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of Trk receptor specificities using BDNF-based neurotrophin chimeras.
    Lai KO; Glass DJ; Geis D; Yancopoulos GD; Ip NY
    J Neurosci Res; 1996 Dec; 46(5):618-29. PubMed ID: 8951673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
    Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
    Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with TrkA immobilizes gp75 in the high affinity nerve growth factor receptor complex.
    Wolf DE; McKinnon CA; Daou MC; Stephens RM; Kaplan DR; Ross AH
    J Biol Chem; 1995 Feb; 270(5):2133-8. PubMed ID: 7836442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-gamma 1 abolishes NGF-promoted peripherin induction but not neurite outgrowth.
    Loeb DM; Stephens RM; Copeland T; Kaplan DR; Greene LA
    J Biol Chem; 1994 Mar; 269(12):8901-10. PubMed ID: 7510697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition, and protein secretion in PC12 cells.
    Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
    J Neurochem; 1998 Aug; 71(2):757-66. PubMed ID: 9681467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J; Vroegop SM; Buxser SE; Neet KE
    J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells.
    Yamashita H; Avraham S; Jiang S; Dikic I; Avraham H
    J Biol Chem; 1999 May; 274(21):15059-65. PubMed ID: 10329710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel juxtamembrane deletion in rat TrkA blocks differentiative but not mitogenic cell signaling in response to nerve growth factor.
    Meakin SO; MacDonald JI
    J Neurochem; 1998 Nov; 71(5):1875-88. PubMed ID: 9798911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.